The Rural and Urban Supply of Clinicians With a DEA Waiver to Prescribe Buprenorphine in 2022 Prior to the Elimination of the Waiver Requirement
Link
Description
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date
04/2025
Organization
WWAMI Rural Health Research Center
Tagged as
Access
· Health disparities
· Illicit drug use
· Policy
· Prescription drug misuse
· Rural-urban differences
· Statistics and data